Skip to main content
OpenTrials

Clinical trial condition

Dyslipidaemias

Explore clinical trials studying Dyslipidaemias. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Dyslipidaemias trial results

Completed

Study to Test GSK256073 in Patients With Dyslipidemia

NCT00903617

Conditions
Dyslipidaemias, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • GSK Investigational Site Pembroke Pines, Florida, United States
  • GSK Investigational Site Indianapolis, Indiana, United States
  • GSK Investigational Site Louisville, Kentucky, United States
  • GSK Investigational Site Auburn, Maine, United States
View Trial Details
Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

NCT01218204

Conditions
Dyslipidaemias, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • GSK Investigational Site Anniston, Alabama, United States
  • GSK Investigational Site Chula Vista, California, United States
  • GSK Investigational Site Stockton, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
View all 21 locations
View Trial Details
Completed

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

NCT00169559

Conditions
Dyslipidaemias, Dyslipidemias, Hyperlipidemias, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
View all 50 locations
View Trial Details

Related conditions